Related Experiment Video

Updated: Jun 20, 2026

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

Influenza A (H1N1) 2009 monovalent vaccine: laboratory confirmation of vaccine breakdowns

Subhash C Arya, Agarwal Nirmala

    Vaccine
    |September 22, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
    07:55

    Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

    Published on: August 29, 2017

    Expression and Purification of Virus-like Particles for Vaccination
    06:17

    Expression and Purification of Virus-like Particles for Vaccination

    Published on: June 2, 2016

    Related Experiment Videos

    Last Updated: Jun 20, 2026

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
    06:34

    An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

    Published on: December 1, 2017

    Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
    07:55

    Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

    Published on: August 29, 2017

    Expression and Purification of Virus-like Particles for Vaccination
    06:17

    Expression and Purification of Virus-like Particles for Vaccination

    Published on: June 2, 2016

    Related Concept Videos

    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
    Leaky Scanning02:28

    Leaky Scanning

    During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
    Vaccinations01:51

    Vaccinations

    Overview

    Articles linked to this work by shared authors, journal, and citation graph.

    Impact of clinical syndrome-wise categorisation of antimicrobial susceptibility profiles on nosocomial isolates in a tertiary care hospital in Delhi, India.

    Journal of global antimicrobial resistance·2016

    Acute flaccid paralysis by non-polio exteroviruses before, during and after eradication of poliomyelitis.

    Saudi medical journal·2016

    Total knee arthroplasty in women with asymptomatic urinary tract infection.

    Journal of orthopaedic surgery (Hong Kong)·2015

    An Evaluation of the Point-of-Care Analyzer, i-Smart 30, for Measurement of Electrolytes.

    Indian journal of clinical biochemistry : IJCB·2014

    Apropos: 'Preliminary evaluation on the efficiency of the kit Platelia Dengue NS1 Ag-ELISA to detect dengue virus in dried Aedes aegypti: a potential tool to improve dengue surveillance'.

    Parasites & vectors·2014

    Comparison of two amoxicillin/clavulanic acid-resistant profiles employing two types of assay disks: A pilot study in 50 isolates from a tertiary care hospital in India.

    Current therapeutic research, clinical and experimental·2014

    Cross-protection and type-replacement over the 17 years after human papillomavirus vaccine introduction in young women.

    Vaccine·2026

    Quantifying the impact of pathogen interactions on vaccine effectiveness estimates in the test-negative design.

    Vaccine·2026

    Designing sero-epidemiological studies to explore immune markers associated with a reduced risk of invasive Klebsiella pneumoniae disease.

    Vaccine·2026

    AEX-1: A Vero cell variant with enhanced permissiveness for influenza virus replication.

    Vaccine·2026

    When models diverge: Harmonizing pneumococcal vaccination cost-effectiveness analyses to inform PCV20 and PCV21 use in US adults.

    Vaccine·2026

    Timeliness of routine childhood vaccination in the Democratic Republic of the Congo: data from national vaccine surveys in 2021/2022, 2023 and 2024.

    Vaccine·2026

    Case Report: Immune-related colitis complicated by Clostridioides difficile-associated colitis.

    Frontiers in immunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us